Related Experiment Video

Updated: Aug 3, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 27, 2013

Optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction

Kent Dauterman1, Eric Topol

  • 1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.

Annals of Medicine
|January 30, 2003
PubMed

Insights

Early reperfusion is key for acute myocardial infarction (AMI). While fibrinolytic therapy improves outcomes, adjunctive treatments and risk stratification, including cardiac rehabilitation and potential defibrillator implantation, are crucial for patient survival.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute myocardial infarction (AMI) is a leading global cause of death.
  • Early and complete myocardial reperfusion is the primary treatment goal.
  • Fibrinolytic therapy is vital for hospitals lacking percutaneous coronary intervention (PCI) capabilities, but has a limited success rate.

Purpose of the Study:

  • To review current strategies for managing acute myocardial infarction (AMI).
  • To evaluate the efficacy of adjunctive therapies in improving clinical outcomes.
  • To outline essential secondary preventive measures and risk stratification protocols for AMI patients.

Main Methods:

  • Review of clinical trial data on fibrinolytic therapy and adjunctive treatments (GUSTO-V, ASSENT-3, HERO-2).
  • Analysis of secondary preventive measures including aspirin, beta-blockers, ACE inhibitors, and statins.
  • Evaluation of risk stratification criteria and recommendations for cardiac rehabilitation and implantable cardioverter-defibrillator (ICD) implantation.

Main Results:

  • Standard fibrinolytic therapy has a 67% success rate.
  • Adjunctive therapies (reduced-dose fibrinolysis with glycoprotein IIb/IIIa inhibitors, or full-dose with enoxaparin/bivalirudin) offer only marginal improvements.
  • Evidence supports the use of aspirin, beta-blockers, ACE inhibitors, and statins for secondary prevention.

Conclusions:

  • Optimal AMI management requires timely reperfusion and comprehensive secondary prevention.
  • Risk stratification is essential, guiding decisions on cardiac rehabilitation and ICD implantation for patients with reduced left ventricular (LV) systolic function.
  • A multi-faceted approach combining pharmacotherapy, lifestyle changes, and device therapy improves long-term outcomes in AMI survivors.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...